Erratum: Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells (Molecular Cancer Research (2013) 11 (230–239) DOI: 10.1158/1541-7786.MCR-12-0632);Balanced Tiam1-Rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells

Molecular Cancer Research

Volumn 11, Issue 3, 2013, Pages 230-239

  Guo, Xingjun ^a   Wang, Min ^a   Jiang, Jianxin ^b   Xie, Chengchen ^a   Peng, Feng ^a   Li, Xu ^a   Tian, Rui ^a   Qin, Renyi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN T LYMPHOMA INVASION AND METASTASIS 1; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; UPREGULATION; WNT SIGNALING PATHWAY;

EID: 84875432990     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-22-0795     Document Type: Erratum

References (38)

1. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008;10:58-62. (Pubitemid 351298114)
2. Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ 2012;344:e2476.
3. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JG. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 2002;417:867-71. (Pubitemid 34670335)
4. Minard ME, Herynk MH, Collard JG, Gallick GE. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 2005;24:2568-73. (Pubitemid 40593047)
5. Chen B, Ding Y, Liu F, Ruan J, Guan J, Huang J, et al. Tiam1, overexpressed in most malignancies, is a novel tumor biomarker. Mol Med Report 2012;5:48-53.
6. Huang J, Ye X, Guan J, Chen B, Li Q, Zheng X, et al.. Tiam1 is associated with hepatocellular carcinoma metastasis. Int J Cancer 2013;132:90-100.
7. Matsuo N, Terao M, Nabeshima Y, Hoshino M. Roles of STEF/Tiam1, guanine nucleotide exchange factors for Rac1, in regulation of growth cone morphology. Mol Cell Neurosci 2003;24:69-81. (Pubitemid 37194534)
8. Bollag G, Crompton AM, Peverly-Mitchell D, Habets GG, Symons M. Activation of Rac1 by human Tiam1. Methods Enzymol 2000;325:51-61.
9. Xu K, Rajagopal S, Klebba I, Dong S, Ji Y, Liu J, et al. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene 2010;29:6533-42.
10. Du X, Wang S, Lu J, Wang Q, Song N, Yang T, et al. Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma. Med Oncol 2012;29:1873-8.
11. Qi Y, Huang B, Yu L, Wang Q, Lan G, Zhang Q. Prognostic value of Tiam1 and Rac1 overexpression in nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 2009;71:163-71.
12. Yang W, Lv S, Liu X, Liu H, Yang W, Hu F. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. Jpn J Clin Oncol 2010;40:1053-9.
13. Liu H, Shi G, Liu X, Wu H, Fan Q, Wang X. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 2011;25:841-8.
14. Hsueh C, Lin JD, Yang CF, Chang YS, Chao TC, Sun JH, et al. Prognostic significance of Tiam1 expression in papillary thyroid carcinoma. Virchows Arch 2011;459:587-93.
15. Hordijk PL, Ten KJ, van der Kammen RA, Michiels F, Oomen LC, Collard JG. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997;278:1464-6. (Pubitemid 27509819)
16. Shepherd TR, KlausSM, Liu X, Ramaswamy S, DeMali KA, Fuentes EJ. The Tiam1 PDZ domain couples to Syndecan1 and promotes cellmatrix adhesion. J Mol Biol 2010;398:730-46.
17. Malliri A, Rygiel TP, van derKammen RA, Song JY, Engers R, Hurlstone AF, et al. The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. J Biol Chem 2006;281:543-8. (Pubitemid 43671217)
18. Buongiorno P, Pethe VV, Charames GS, Esufali S, Bapat B. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells. Mol Cancer 2008;7:73.
19. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008;133:340-53. (Pubitemid 351508298)
20. Sonderegger S, Pollheimer J, Knofler M. Wnt signalling in implantation, decidualisation and placental differentiation-review. Placenta 2010; 31:839-47.
21. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
22. Chauhan BK, Lou M, Zheng Y, Lang RA. Balanced Rac1 and RhoA activities regulate cell shape and drive invagination morphogenesis in epithelia. Proc Natl Acad Sci U S A 2011;108:18289-94.
23. Sabbatini ME, Bi Y, Ji B, Ernst SA, Williams JA. CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini. Am J Physiol Cell Physiol 2010;298:C592-601.
24. Wildenberg GA, Dohn MR, Carnahan RH, Davis MA, Lobdell NA, Settleman J, et al. p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell 2006;127:1027-39. (Pubitemid 44792253)
25. Leeuwen FN, Kain HE, Kammen RA, Michiels F, Kranenburg OW, Collard JG. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho. J Cell Biol 1997;139:797-807. (Pubitemid 27485843)
26. Sander EE, Ten KJ, van Delft S, van der Kammen RA, Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999;147:1009-22.
27. Timpson P, McGhee EJ, Morton JP, von Kriegsheim A, Schwarz JP, Karim SA, et al. Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Cancer Res 2011;71:747-57.
28. Frigeri M, De Dosso S, Castillo-Fernandez O, Feuerlein K, Neuenschwander H, Saletti P. Chemotherapy in patients with advanced pancreatic cancer: too close to death? Support Care Cancer 2013;21:157-63.
29. Herbrand U, Ahmadian MR. p190-RhoGAP as an integral component of the Tiam1/Rac1-induced downregulation of Rho. Biol Chem 2006;387:311-7.
30. Cottonham CL, Kaneko S, Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 2010;285:35293-302.
31. Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y, et al. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis ofHCC patients. Int J Cancer 2009;124:653-8.
32. Stebel A, Brachetti C, Kunkel M, Schmidt M, Fritz G. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1. Oncol Rep 2009;21:217-22.
33. Walch A, Seidl S, Hermannstadter C, Rauser S, Deplazes J, Langer R, et al. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer. Mod Pathol 2008;21:544-52. (Pubitemid 351589660)
34. Esufali S, Bapat B. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of betacatenin and TCF/LEF-mediated transcriptional activation. Oncogene 2004;23:8260-71. (Pubitemid 39531837)
35. Adam L, Vadlamudi RK, McCrea P, Kumar R. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem 2001;276:28443-50.
36. Yamazaki D, Kurisu S, Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 2009;28:1570-83.
37. Taniuchi K, Iwasaki S, Saibara T. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation. Int J Oncol 2011;39:1243-52.
38. Della PM, Giagulli C, Laudanna C, Scarpa A, Sorio C. RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones. Mol Cancer 2010;9:61.